» Articles » PMID: 34514017

Increased Capsule Thickness and Hypermotility Are Traits of Carbapenem-Resistant ST3 Strains Causing Fulminant Infection

Overview
Date 2021 Sep 13
PMID 34514017
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: is a successful nosocomial pathogen, causing severe, life-threatening infections in hospitalized patients, including pneumonia and bloodstream infections. The spread of carbapenem-resistant (CRAB) strains is a major health threat worldwide. The successful spread of CRAB is mostly due to its highly plastic genome. Although some virulence factors associated with CRAB have been uncovered, many mechanisms contributing to its success are not fully understood.

Methods: Here we describe strains of CRAB that were isolated from fulminant cases in 2 hospitals in Israel. These isolates show a rare hypermucoid (HM) phenotype and were investigated using phenotypic assays, comparative genomics, and an in vivo model.

Results: The 3 isolates belonged to the ST3 international clonal type and were closely related to each other, as shown by Fourier-transform infrared spectroscopy and phylogenetic analyses. These isolates possessed thickened capsules and a dense filamentous extracellular polysaccharides matrix as shown by transmission electron microscopy (TEM), and overexpressed the capsule polysaccharide synthesis pathway-related gene.

Conclusions: The HM isolates possessed a unique combination of virulence genes involved in iron metabolism, protein secretion, adherence, and membrane glycosylation. HM strains were more virulent than control strains in 2 infection models. In conclusion, our findings demonstrated several virulence factors, all present in 3 CRAB isolates with rare hypermucoid phenotypes.

Citing Articles

Phage-encoded depolymerases as a strategy for combating multidrug-resistant .

Islam M, Mahbub N, Shin W, Oh M Front Cell Infect Microbiol. 2024; 14:1462620.

PMID: 39512587 PMC: 11540826. DOI: 10.3389/fcimb.2024.1462620.


Exploring Roles of the Polysaccharide Capsule in Pathogenesis of Hypervirulent Clinical Isolate Lac-4.

Bjanes E, Koh T, Qayum T, Zurich R, McCabe S, Hampel K Antibiotics (Basel). 2024; 13(1).

PMID: 38275320 PMC: 10812722. DOI: 10.3390/antibiotics13010010.


Phenotypic and Genomic Characterization of Nine String-Positive Carbapenem-Resistant Acinetobacter baumannii Isolates from Israel.

Rakovitsky N, Lurie-Weinberger M, Hameir A, Wulffhart L, Keren Paz A, Schwartz D Microbiol Spectr. 2023; :e0300222.

PMID: 36719216 PMC: 10100839. DOI: 10.1128/spectrum.03002-22.


The Wzi outer membrane protein mediates assembly of a tight capsular polysaccharide layer on the Acinetobacter baumannii cell surface.

Tickner J, Hawas S, Totsika M, Kenyon J Sci Rep. 2021; 11(1):21741.

PMID: 34741090 PMC: 8571296. DOI: 10.1038/s41598-021-01206-5.

References
1.
Abdollahi S, Rasooli I, Mousavi Gargari S . The role of TonB-dependent copper receptor in virulence of Acinetobacter baumannii. Infect Genet Evol. 2018; 60:181-190. DOI: 10.1016/j.meegid.2018.03.001. View

2.
Bassetti M, Echols R, Matsunaga Y, Ariyasu M, Doi Y, Ferrer R . Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3.... Lancet Infect Dis. 2020; 21(2):226-240. DOI: 10.1016/S1473-3099(20)30796-9. View

3.
Hua X, Zhou Z, Yang Q, Shi Q, Xu Q, Wang J . Evolution of : International Clone II, More Resistance to Ceftazidime, Mutation in . Front Microbiol. 2017; 8:1256. PMC: 5502287. DOI: 10.3389/fmicb.2017.01256. View

4.
Pan Y, Lin T, Chen C, Chen Y, Hsieh P, Hsu C . Genetic analysis of capsular polysaccharide synthesis gene clusters in 79 capsular types of Klebsiella spp. Sci Rep. 2015; 5:15573. PMC: 4616057. DOI: 10.1038/srep15573. View

5.
Peleg A, Jara S, Monga D, Eliopoulos G, Moellering Jr R, Mylonakis E . Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother. 2009; 53(6):2605-9. PMC: 2687231. DOI: 10.1128/AAC.01533-08. View